HIV infections Trials in Plantation, United States
Conditions / HIV infections / Plantation, United States
HIV infections has been the subject of sustained clinical investigation across multiple research sites.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00043966 | Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects | COMPLETED | PHASE3 |
| NCT00232908 | QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection | COMPLETED | PHASE4 |
| NCT00046345 | Atazanavir for HIV Infected Individuals: An Early Access Program | NO_LONGER_AVAILABLE | — |
| NCT00245739 | TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens. | APPROVED_FOR_MARKETING | — |
| NCT00488059 | A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients | TERMINATED | PHASE4 |
| NCT00337701 | BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection | COMPLETED | PHASE4 |
| NCT00082316 | Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain | COMPLETED | PHASE2 |
| NCT00135395 | A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen | COMPLETED | PHASE3 |
| NCT00097799 | Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection | APPROVED_FOR_MARKETING | — |
| NCT00135382 | Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen | COMPLETED | PHASE3 |